These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 28938547)
21. Long non-coding RNA AOC4P suppresses hepatocellular carcinoma metastasis by enhancing vimentin degradation and inhibiting epithelial-mesenchymal transition. Wang TH; Lin YS; Chen Y; Yeh CT; Huang YL; Hsieh TH; Shieh TM; Hsueh C; Chen TC Oncotarget; 2015 Sep; 6(27):23342-57. PubMed ID: 26160837 [TBL] [Abstract][Full Text] [Related]
22. MicroRNA-491 is involved in metastasis of hepatocellular carcinoma by inhibitions of matrix metalloproteinase and epithelial to mesenchymal transition. Zhou Y; Li Y; Ye J; Jiang R; Yan H; Yang X; Liu Q; Zhang J Liver Int; 2013 Sep; 33(8):1271-80. PubMed ID: 23725476 [TBL] [Abstract][Full Text] [Related]
23. Lipocalin-2 negatively modulates the epithelial-to-mesenchymal transition in hepatocellular carcinoma through the epidermal growth factor (TGF-beta1)/Lcn2/Twist1 pathway. Wang YP; Yu GR; Lee MJ; Lee SY; Chu IS; Leem SH; Kim DG Hepatology; 2013 Oct; 58(4):1349-61. PubMed ID: 23696034 [TBL] [Abstract][Full Text] [Related]
24. HNRNPAB induces epithelial-mesenchymal transition and promotes metastasis of hepatocellular carcinoma by transcriptionally activating SNAIL. Zhou ZJ; Dai Z; Zhou SL; Hu ZQ; Chen Q; Zhao YM; Shi YH; Gao Q; Wu WZ; Qiu SJ; Zhou J; Fan J Cancer Res; 2014 May; 74(10):2750-62. PubMed ID: 24638979 [TBL] [Abstract][Full Text] [Related]
26. Glypican-3 promotes epithelial-mesenchymal transition of hepatocellular carcinoma cells through ERK signaling pathway. Wu Y; Liu H; Weng H; Zhang X; Li P; Fan CL; Li B; Dong PL; Li L; Dooley S; Ding HG Int J Oncol; 2015 Mar; 46(3):1275-85. PubMed ID: 25572615 [TBL] [Abstract][Full Text] [Related]
27. STAT3 cooperates with Twist to mediate epithelial-mesenchymal transition in human hepatocellular carcinoma cells. Zhang C; Guo F; Xu G; Ma J; Shao F Oncol Rep; 2015 Apr; 33(4):1872-82. PubMed ID: 25653024 [TBL] [Abstract][Full Text] [Related]
28. Lamp2 inhibits epithelial-mesenchymal transition by suppressing Snail expression in HCC. Zheng H; Yang Y; Ye C; Li PP; Wang ZG; Xing H; Ren H; Zhou WP Oncotarget; 2018 Jul; 9(54):30240-30252. PubMed ID: 30100986 [TBL] [Abstract][Full Text] [Related]
29. Reduced expression of transcriptional intermediary factor 1 gamma promotes metastasis and indicates poor prognosis of hepatocellular carcinoma. Ding ZY; Jin GN; Wang W; Chen WX; Wu YH; Ai X; Chen L; Zhang WG; Liang HF; Laurence A; Zhang MZ; Datta PK; Zhang B; Chen XP Hepatology; 2014 Nov; 60(5):1620-36. PubMed ID: 24954480 [TBL] [Abstract][Full Text] [Related]
30. Reciprocal activation between ATPase inhibitory factor 1 and NF-κB drives hepatocellular carcinoma angiogenesis and metastasis. Song R; Song H; Liang Y; Yin D; Zhang H; Zheng T; Wang J; Lu Z; Song X; Pei T; Qin Y; Li Y; Xie C; Sun B; Shi H; Li S; Meng X; Yang G; Pan S; Zhu J; Qi S; Jiang H; Zhang Z; Liu L Hepatology; 2014 Nov; 60(5):1659-73. PubMed ID: 25042864 [TBL] [Abstract][Full Text] [Related]
31. Block of proliferation 1 (BOP1) plays an oncogenic role in hepatocellular carcinoma by promoting epithelial-to-mesenchymal transition. Chung KY; Cheng IK; Ching AK; Chu JH; Lai PB; Wong N Hepatology; 2011 Jul; 54(1):307-18. PubMed ID: 21520196 [TBL] [Abstract][Full Text] [Related]
32. Chemokine ligand 20 enhances progression of hepatocellular carcinoma via epithelial-mesenchymal transition. Hou KZ; Fu ZQ; Gong H World J Gastroenterol; 2015 Jan; 21(2):475-83. PubMed ID: 25593462 [TBL] [Abstract][Full Text] [Related]
33. FGG promotes migration and invasion in hepatocellular carcinoma cells through activating epithelial to mesenchymal transition. Zhang X; Wang F; Huang Y; Ke K; Zhao B; Chen L; Liao N; Wang L; Li Q; Liu X; Wang Y; Liu J Cancer Manag Res; 2019; 11():1653-1665. PubMed ID: 30863175 [TBL] [Abstract][Full Text] [Related]
34. Loss of miR-638 promotes invasion and epithelial-mesenchymal transition by targeting SOX2 in hepatocellular carcinoma. Zhang Y; Zhang D; Jiang J; Dong L Oncol Rep; 2017 Jan; 37(1):323-332. PubMed ID: 27878280 [TBL] [Abstract][Full Text] [Related]
35. Sema3d Restrained Hepatocellular Carcinoma Progression Through Inactivating Pi3k/Akt Signaling Li Y; Xu C; Sun B; Zhong F; Cao M; Yang L Front Oncol; 2022; 12():913498. PubMed ID: 35957887 [TBL] [Abstract][Full Text] [Related]
36. ZEB2 promotes vasculogenic mimicry by TGF-β1 induced epithelial-to-mesenchymal transition in hepatocellular carcinoma. Yang Z; Sun B; Li Y; Zhao X; Zhao X; Gu Q; An J; Dong X; Liu F; Wang Y Exp Mol Pathol; 2015 Jun; 98(3):352-9. PubMed ID: 25818166 [TBL] [Abstract][Full Text] [Related]
37. Silencing of GP73 inhibits invasion and metastasis via suppression of epithelial-mesenchymal transition in hepatocellular carcinoma. Yang Y; Liu Q; Zhang H; Zhao H; Mao R; Li Z; Ya S; Jia C; Bao Y Oncol Rep; 2017 Feb; 37(2):1182-1188. PubMed ID: 28075476 [TBL] [Abstract][Full Text] [Related]
38. Coexpression of gene Oct4 and Nanog initiates stem cell characteristics in hepatocellular carcinoma and promotes epithelial-mesenchymal transition through activation of Stat3/Snail signaling. Yin X; Zhang BH; Zheng SS; Gao DM; Qiu SJ; Wu WZ; Ren ZG J Hematol Oncol; 2015 Mar; 8():23. PubMed ID: 25879771 [TBL] [Abstract][Full Text] [Related]
39. MMP16 promotes tumor metastasis and indicates poor prognosis in hepatocellular carcinoma. Shen Z; Wang X; Yu X; Zhang Y; Qin L Oncotarget; 2017 Sep; 8(42):72197-72204. PubMed ID: 29069779 [TBL] [Abstract][Full Text] [Related]
40. Promotion of hepatocellular carcinoma metastasis through matrix metalloproteinase activation by epithelial-mesenchymal transition regulator Twist1. Zhao XL; Sun T; Che N; Sun D; Zhao N; Dong XY; Gu Q; Yao Z; Sun BC J Cell Mol Med; 2011 Mar; 15(3):691-700. PubMed ID: 20219012 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]